Lexaria Bioscience (LEXX) Income towards Parent Company (2017 - 2026)
Lexaria Bioscience's Income towards Parent Company was -$1.99 million in fiscal Q3 2026 (quarter ended May 31, 2026), compared with -$3.79 million a year earlier.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Income towards Parent Company (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Lexaria Bioscience's Income towards Parent Company was -$7.73 million through May 31, 2026; for FY2025 (ended Aug 31, 2025), it came in at -$11.9 million.
- In earlier fiscal years, Income towards Parent Company was $5.8 million in FY2024 (-13.4%), $6.7 million in FY2023, -$7.27 million in FY2022 and -$4.03 million in FY2021.
- Quarterly Income towards Parent Company has moved between -$3.79 million (fiscal Q3 2025) and $9.41 million (fiscal Q4 2024) over five years.
- Per Business Quant data, LEXX's Income towards Parent Company in the three fiscal quarters before Q3 2026 was -$1.45 million (Q2 2026), -$1.6 million (Q1 2026) and -$2.7 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Lexaria Bioscience | 3.04 Mn | -12.61 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -1.99 Mn |
| Feb 28, 2026 | -1.45 Mn |
| Nov 30, 2025 | -1.60 Mn |
| Aug 31, 2025 | -2.70 Mn |
| May 31, 2025 | -3.79 Mn |
| Feb 28, 2025 | -2.71 Mn |
| Nov 30, 2024 | -2.70 Mn |
| Aug 31, 2024 | 9.41 Mn |
| May 31, 2024 | -1.78 Mn |
| Feb 29, 2024 | -649,539.00 |
| Nov 30, 2023 | -1.18 Mn |
| Aug 31, 2023 | 1.20 Mn |
| May 31, 2023 | -2.37 Mn |
| Feb 28, 2023 | -1.30 Mn |
| Nov 30, 2022 | -1.76 Mn |
| Aug 31, 2022 | -1.47 Mn |
| May 31, 2022 | -2.38 Mn |
| Feb 28, 2022 | -1.43 Mn |
| Nov 30, 2021 | -1.99 Mn |
| Aug 31, 2021 | -1.18 Mn |
API Access
Lexaria Bioscience Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();